C07K14/68 - CPC Classification Index

#1

20250129118

2025-04-24

MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE

#2

20240287154

2024-08-29

MC3R AGONIST PEPTIDES

#3

20240190914

2024-06-13

METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS

#4

20240182519

2024-06-06

MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN

#5

20230322886

2023-10-12

RECOMBINANT PROTEIN COMPRISING MULTIPLE MULTI-PEPTIDE SETS, PHARMACEUTICAL COMPOSITION COMPRISING THE RECOMBINANT PROTEIN, AND METHOD FOR PREPARING THE RECOMBINANT PROTEIN

#6

20230167154

2023-06-01

Melanocortin 1 receptor ligands and methods of use

#7

20210221867

2021-07-22

Compounds Capable of Binding to Melanocortin 4 Receptor

#8

20210163536

2021-06-03

MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN

#9

20210101934

2021-04-08

Bovine adrenal medulla peptide 8-22 compounds and methods of use thereof for treating pain

#10

20210061852

2021-03-04

Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

#11

20200339631

2020-10-29

Melanocortin-1 receptor-specific peptides for cytokine storm and inflammation therapy

#12

20200123216

2020-04-23

COMPOUNDS WITH REDUCED RING SIZE FOR USE IN DIAGNOSING AND TREATING MELANOMA, INCLUDING METASTATIC MELANOMA AND METHODS RELATED TO SAME

#13

20200017546

2020-01-16

Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

#14

20200002376

2020-01-02

Melanocortin 1 receptor ligands and methods of use

#15

20190309022

2019-10-10

Modulators of melanocortin receptors

#16

20190106474

2019-04-11

Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

#17

20190062374

2019-02-28

MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN

#18

20180319843

2018-11-08

Compositions and methods for treating central nervous system (CNS) disorders and mood disorders

#19

20180319842

2018-11-08

Compounds and methods for treating pain

#20

20180311304

2018-11-01

Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N

#21

20180194803

2018-07-12

Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

#22

20180148478

2018-05-31

Melanocortin receptor-specific peptide with C-terminal naphthylalanine

#23

20180118784

2018-05-03

MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN

#24

20170296620

2017-10-19

Bis-sulfhydryl macrocyclization systems

#25

20170218017

2017-08-03

Melanocortin 1 receptor ligands and methods of use

#26

20170145056

2017-05-25

Melanocortin-1 receptor-specific linear peptides

#27

20170081383

2017-03-23

MELANOCORTIN ANALOGS HAVING ENHANCED ACTIVITY AND TRANSPORT

#28

20170020953

2017-01-26

Methods for the treatment of depression and anxiety

#29

20170020952

2017-01-26

Methods for the treatment of central nervous system (CNS) disorders and mood disorders

#30

20170008931

2017-01-12

Melanocortin-1 receptor-specific cyclic hexapeptides

#31

20160176925

2016-06-23

Melanocortin receptor ligands modified with hydantoin

#32

20160175384

2016-06-23

Melanotropin ligands for skin care

#33

20160095896

2016-04-07

Bis-sulfhydryl macrocyclization systems

#34

20160074469

2016-03-17

Alpha-and gamma-MSH analogues

#35

20150239952

2015-08-27

Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

#36

20150157747

2015-06-11

Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

#37

20150119341

2015-04-30

Melanocortin-1 receptor-specific linear peptides

#38

20150045293

2015-02-12

Melanocortin analogs having enhanced activity and transport

#39

20150038434

2015-02-05

Melanocortin-1 receptor-specific cyclic peptides

#40

20140329743

2014-11-06

Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

#41

20140155328

2014-06-05

Alpha- and gamma-MSH analogues

#42

20140135473

2014-05-15

Bis-sulfhydryl macrocyclization systems

#43

20140011730

2014-01-09

Melanocortin receptor ligands modified with hydantoin

#44

20130296256

2013-11-07

Melanocortin-1 receptor-specific cyclic peptides

#45

20130012432

2013-01-10

Peptides for Treatment of Obesity

#46

20120270812

2012-10-25

COMPOSITIONS, METHODS, AND KITS FOR DETERMINING AN ALKYL TRANSFERASE

#47

20120225831

2012-09-06

Melanocortin-1 receptor-specific linear peptides

#48

20120225828

2012-09-06

Melanocortin-1 receptor-specific cyclic peptides

#49

20120225816

2012-09-06

Pharmaceutical compositions of melanocortin receptor ligands

#50

20120225016

2012-09-06

Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

#51

20120107237

2012-05-03

Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

#52

20120015873

2012-01-19

Melanocortin analogs with antimicrobial activity

#53

20110312878

2011-12-22

PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS

#54

20100184646

2010-07-22

Melanocortin receptor ligands modified with hydantoin

#55

20100184628

2010-07-22

Bis-sulfhydryl macrocyclization systems

#56

20100056433

2010-03-04

Novel Peptides for Use in the Treatment of Obesity

#57

20100048465

2010-02-25

Peptide mimics of melanocyte stimulating hormone

#58

20100016238

2010-01-21

Peptides for Use in the Treatment of Obesity

#59

20100016237

2010-01-21

Novel Peptides for Use in the Treatment of Obesity

#60

20090186020

2009-07-23

Melanocortin receptor binding mimetibodies, compositions, methods and uses

#61

20090088553

2009-04-02

Bis-sulfhydryl macrocyclization systems

#62

20090088388

2009-04-02

Peptides for Use In Treating Obesity

#63

20090047711

2009-02-19

Bis-sulfhydryl macrocyclization systems

#64

20090011997

2009-01-08

Bifunctional hormone having alpha-MSH activity and natriuretic peptide activity and uses thereof

#65

20080306008

2008-12-11

Peptides for Use in the Treatment of Obesity

#66

20080280820

2008-11-13

Novel Peptides for Use in the Treatment of Obesity

#67

20080255033

2008-10-16

Metallopeptide gamma-Melanocyte Stimulating Hormone Compounds

#68

20080234467

2008-09-25

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

#69

20080227954

2008-09-18

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

#70

20080200366

2008-08-21

Trimeric Peptides for Use in Treating Obesity

#71

20080177036

2008-07-24

Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity

#72

20080176806

2008-07-24

Therapeutic uses of tri-, tetra-, penta-, and polypeptides

#73

20080146779

2008-06-19

Novel Melanocortin Receptor Templates, Peptides, and Use Thereof

#74

20080146496

2008-06-19

Novel Melanocortin Receptor Templates, Peptides, and Use Thereof

#75

20080139785

2008-06-12

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

#76

20080039387

2008-02-14

Novel Peptides for Use in the Treatment of Obesity

#77

20080032931

2008-02-07

ACTIVATABLE CLOSTRIDIAL TOXINS

#78

20080032930

2008-02-07

Activatable clostridial toxins

#79

20080015152

2008-01-17

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

#80

20070293418

2007-12-20

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

#81

20070244054

2007-10-18

Peptides for use in treating obesity

#82

20070105759

2007-05-10

Melanocortin receptor 4 (mc4) agonists and their uses

#83

20070027091

2007-02-01

Melanocortin receptor agonists

#84

20060258590

2006-11-16

Melanocortin receptor templates, peptides and use thereof

#85

20060122121

2006-06-08

Modified alpha-MSH peptides and derivatives thereof

#86

20060105951

2006-05-18

Melanocortin receptor binding mimetibodies, compositions, methods and uses

#87

20060063699

2006-03-23

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

#88

20050282739

2005-12-22

Metallopeptide compounds

#89

20050239711

2005-10-27

Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity

#90

20050164914

2005-07-28

Metallopeptide compositions for treatment of sexual dysfunction

#91

20050130901

2005-06-16

Modified α-MSH peptides and derivatives thereof

#92

20050038230

2005-02-17

Linear and cyclic melanocortin receptor-specific peptides